BioNTech SE - American Depositary Shares (NQ:BNTX)

97.09 +0.19 (+0.20%)

Delayed Quote Updated: 12:25 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

73 74 Next >

Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today ↗

October 28, 2022

The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster.

Via The Motley Fool

A New BioTech Research Race Is Focused On Improving Life For MS Patients ↗

October 27, 2022

When the world is focused on a global pandemic no one saw coming four years ago, the attention given to escalating diseases with no known cure can be hidden from the public consciousness. This is...

Via Benzinga

Is BioNTech a Good Long-Term Buy? ↗

October 27, 2022

BioNTech has a burgeoning oncology portfolio up its sleeve.

Via The Motley Fool

Are Pfizer and Moderna Stocks Buys With a Potential COVID Surge Coming? ↗

October 26, 2022

There's still considerable near-term uncertainty for both of these vaccine makers.

Via The Motley Fool

JP Morgan Maintains Neutral Rating for BioNTech: Here's What You Need To Know ↗

October 24, 2022

JP Morgan has decided to maintain its Neutral rating of BioNTech (NASDAQ:BNTX) and lower its price target from $183.00 to $132.00. Shares of BioNTech are trading down 0.68% over the last 24 hours, at...

Via Benzinga

BioNTech to Report Third Quarter 2022 Financial Results and Operational Update on November 7, 2022

October 24, 2022

From BioNTech SE

Via GlobeNewswire

Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday ↗

October 24, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.

Via Benzinga

Moderna, Amazon, Tesla, And Other Big Gainers From Friday ↗

October 24, 2022

U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Why Novavax Stock Rose 12.57% on Friday ↗

October 21, 2022

Investors did an about-face after the stock slumped earlier in the week.

Via The Motley Fool

Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today? ↗

October 21, 2022

Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit?

Via InvestorPlace

Twitter Rebuffs Elon Musk Layoff Plans Report, Toyota Cuts 2023's Production Target, Vaccine Makers Expect 3x Price Increase In COVID-19 Shot: Top Stories Friday, Oct. 21 ↗

October 21, 2022

Bloomberg

Via Benzinga

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

October 21, 2022

Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.

Via Benzinga

Vaccine Makers Mull Price Increase For COVID-19 Boosters Amid Falling Demand ↗

October 21, 2022

Via Benzinga

Boston University's COVID-19 Created In Lab Research Comes Under Scrutiny ↗

October 20, 2022

Boston University created an artificial form of COVID-19 in a laboratory. Now, U.S. health officials have launched an inquiry into a controversial study. The Boston University research was designed to...

Via Benzinga

Why Moderna Stock Dropped Today ↗

October 19, 2022

Competition is intensifying.

Via The Motley Fool

Why Novavax Stock Couldn't Win on Wednesday ↗

October 19, 2022

FDA authorization isn't necessarily a slam dunk for a company.

Via The Motley Fool

European Advisory Committee Backs Pfizer/BioNTech's COVID Shot For Younger Kids ↗

October 19, 2022

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union

October 19, 2022

From BioNTech SE

Via GlobeNewswire

Why BioNTech SE And Novavax Shares Are Diving ↗

October 18, 2022

BioNTech SE - ADR (NASDAQ: BNTX) and Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 4.07% to $133.28 and 7.68% to $18.76, respectively, ahead of the close of Tuesday's session. Vaccine stock

Via Benzinga

3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off ↗

October 16, 2022

All three of these medical stocks offer a high-yield dividend.

Via The Motley Fool

Bulls And Bears Of The Week: Amazon, Tesla, Apple, Meta And Why An Analyst Is Turning Less Positive On 2 Legacy Automakers ↗

October 15, 2022

Benzinga examined the prospects for many investors' favorite stocks over the past week — here's a look at some of our top stories.

Via Benzinga

Why Novavax Stock Had an Ugly Friday ↗

October 14, 2022

Investors ding the biotech's shares one day after it reported quite good news about an experimental vaccine.

Via The Motley Fool

Pfizer/BioNTech's Updated Omicron Adapted COVID-19 Shot Increases Neutralizing Antibodies Above Pre-Booster Levels ↗

October 13, 2022

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ:

Via Benzinga

Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older

October 13, 2022

From BioNTech SE

Via GlobeNewswire

Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older

October 13, 2022

From Pfizer Inc.

Via Business Wire

These 2 Stocks Gave Investors a Nice Surprise Wednesday ↗

October 12, 2022

Markets moved slightly lower in advance of the latest data on inflation.

Via The Motley Fool

Why Pfizer Partner BioNTech SE Shares Are Trading Higher ↗

October 12, 2022

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 5.37% to $136.45 going into the close of Wednesday's trading session after the FDA granted Emergency Use Authorization to the company's...

Via Benzinga

FDA Authorizes Pfizer/BioNtech's Updated COVID-19 Booster Shots For Kids 5-11 Years ↗

October 12, 2022

Via Benzinga

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age

October 12, 2022

From BioNTech SE

Via GlobeNewswire

Moderna, BioNTech And Some Other Big Stocks Moving Higher On Wednesday ↗

October 12, 2022

U.S. stocks traded mostly higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

73 74 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.